Antineoplaston promoter Burzynski indicted by Houston federal grand jury.

Executive Summary

ANTINEOPLASTON PROMOTER INDICTED BY HOUSTON FEDERAL GRAND JURY on 75 counts of mail fraud, contempt and FDA violations, Southern Texas U.S. Attorney Gaynelle Griffin Jones announces Nov. 20. Thirty four counts of the federal indictment charge Houston physician Stanislow Burzynski, MD, with mail fraud, while 40 counts cite Burzynski for introducing an unapproved drug into interstate commerce. The physician has treated more than 2,500 patients with antineoplaston for AIDS, arthritis, cancers, precancerous conditions, lupus, multiple sclerosis and Parkinson's disease, the South Texas U.S. Attorney states.